Issues related to Medicare drug coverage, specialty pharmacy, and general prescription drug pricing policy; Issues related to the continuation of telehealth flexibilities.
2025 · 4th Quarter (Oct 1 - Dec 31)
CIGNA CORPORATION AND SUBSIDIARIES
Filed by TIBER CREEK GROUP.
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 18, 2026
- Income
- $90,000.00
- Expenses
- Not reported
- Registrant
- TIBER CREEK GROUP
- Filing UUID
- 92545722-c189-490d-9c0f-a241ec1b387b
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to proposals impacting employer-sponsored insurance; Issues related to pharmacy and prescription drug pricing policy; Issues related to H.R. 247/S. 846 - Health Care Affordability Act of 2025; Issues related to the extension of Enhanced Advanced Premium Tax Credits (EAPTCs) in the American Rescue Plan Act (PL 117-2) and the Inflation Reduction Act (PL 117-169).
Pharmacy issues related to the National Defense Authorization Act for Fiscal Year 2026 (PL 119-60).
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.